8-K//Current report
Y-mAbs Therapeutics, Inc. 8-K
Accession 0001558370-25-010846
CIK 0001722964operating
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 7:18 AM ET
Size
656.0 KB
Accession
0001558370-25-010846
Documents
- 8-Kymab-20250808x8k.htmPrimary
8-K
- EX-99.1ymab-20250808xex99d1.htm
EX-99.1
- GRAPHICymab-20250808xex99d1002.jpg
GRAPHIC
- EX-101.SCHymab-20250808.xsd
EX-101.SCH
- EX-101.LABymab-20250808_lab.xml
EX-101.LAB
- EX-101.PREymab-20250808_pre.xml
EX-101.PRE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001558370-25-010846-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLymab-20250808x8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Y-mAbs Therapeutics, Inc.
CIK 0001722964
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001722964
Filing Metadata
- Form type
- 8-K
- Filed
- Aug 7, 8:00 PM ET
- Accepted
- Aug 8, 7:18 AM ET
- Size
- 656.0 KB